The biotechnology sector in India is expected to achieve revenue of US$ 11.6 billion by 2017, growing at a compound annual growth rate (CAGR) of 22 per cent, according to a recent report by Ernst & Young (E&Y). The key growth drivers of the US$ 4.3 billion industry include strong domestic demand for biotech products, growth in contract services, focus on R&D initiatives and strong government support for the sector.
Revenue from biotech exports reached US$ 2.2 billion in FY13, accounting for more than half (51 per cent) of total industry revenues. During FY13, revenue from exports increased at a CAGR of 25.1 per cent to US$ 2.2 billion from US$ 0.4 billion. According to data released by the Department of Industrial Policy and Promotion (DIPP), the drugs and pharmaceuticals sector has attracted foreign direct investment (FDI) worth Rs 54,780.65 crore (US$ 8.81 billion) between April 2000 and September 2013.

INDIAN Biotech INDUSTRY AT A Glance IN 2012 - 2013
INDIAN Biotech INDUSTRY AT A Glance IN 2011 - 2012
Biotechnology Industry Research Assistance Council (BIRAC)
All India Biotech Association (AIBA)
back to biotechnology INDUSTRY
![]() |
INDIAN INDUSTRIES |